Systematic review: chronic viral hepatitis and metabolic derangement

CC Wang, PN Cheng, JH Kao - Alimentary pharmacology & …, 2020 - Wiley Online Library
Background The liver has a critical role in the metabolism of glucose and lipids. Chronic
hepatitis B virus (HBV) or hepatitis C virus (HCV) infection leads to a spectrum of liver …

Natural history of hepatitis C

S Lingala, MG Ghany - Gastroenterology Clinics, 2015 - gastro.theclinics.com
Hepatitis C virus (HCV) infection is an important cause of cirrhosis and hepatocellular
carcinoma (HCC) worldwide. 1 It is also a common cause of chronic liver disease in the …

Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis

R Moucari, T Asselah, D Cazals–Hatem, H Voitot… - Gastroenterology, 2008 - Elsevier
BACKGROUND & AIMS: Our study was designed to test the association between insulin
resistance (IR) and hepatitis C virus (HCV) genotypes using serum HCV RNA level and liver …

Diagnostic value of a computerized hepatorenal index for sonographic quantification of liver steatosis

M Webb, H Yeshua, S Zelber-Sagi… - American Journal of …, 2009 - Am Roentgen Ray Soc
OBJECTIVE. Quantification of liver steatosis is clinically relevant in various liver diseases but
cannot be done by conventional sonography, which only provides a qualitative assessment …

Genotype 3 is associated with accelerated fibrosis progression in chronic hepatitis C

PY Bochud, T Cai, K Overbeck, M Bochud… - Journal of …, 2009 - Elsevier
BACKGROUND/AIMS: While several risk factors for the histological progression of chronic
hepatitis C have been identified, the contribution of HCV genotypes to liver fibrosis evolution …

Features associated with success rate and performance of FibroScan measurements for the diagnosis of cirrhosis in HCV patients: a prospective study of 935 patients

A Kettaneh, P Marcellin, C Douvin, R Poupon, M Ziol… - Journal of …, 2007 - Elsevier
BACKGROUND/AIMS: FibroScan®, a non-invasive procedure for the diagnosis of cirrhosis,
benefits only patients for which at least 10 valid shots are acquired. We investigated features …

NAFLD and NASH in HCV infection: prevalence and significance in hepatic and extrahepatic manifestations

LE Adinolfi, L Rinaldi, B Guerrera, L Restivo… - International journal of …, 2016 - mdpi.com
The aim of this paper is to review and up to date the prevalence of hepatitis C virus (HCV)-
associated non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis …

Role of hepatitis C virus genotype 3 in liver fibrosis progression–a systematic review and meta‐analysis

A Probst, T Dang, M Bochud, M Egger… - Journal of viral …, 2011 - Wiley Online Library
The progression of liver fibrosis in chronic hepatitis C has long been considered to be
independent from viral genotypes. However, recent studies suggest an association between …

Weight-related effects on disease progression in the hepatitis C antiviral long-term treatment against cirrhosis trial

JE Everhart, AS Lok, HY Kim, TR Morgan, KL Lindsay… - Gastroenterology, 2009 - Elsevier
BACKGROUND & AIMS: With the limited efficacy of current therapy for chronic hepatitis C,
modifiable risk factors for liver disease progression are important to identify. Because …

[PDF][PDF] Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: role of insulin resistance and hepatic steatosis

E Bugianesi, G Marchesini, E Gentilcore, IHY Cua… - …, 2006 - Wiley Online Library
Hepatic steatosis has been associated with fibrosis, but it is unknown whether the latter is
independent of the etiology of fat infiltration. We analyzed the relationship between clinical …